Strontium doping of bone graft extender.

Acta orthopaedica (2011-09-08)
Marianne T Vestermark, Ellen-Margrethe Hauge, Kjeld Soballe, Joan E Bechtold, Thomas Jakobsen, Jorgen Baas

Allografts are often used during revision hip replacement surgery for stabilization of the implant. Resorption of the allograft may exceed new bone formation, and instability of the prosthesis can develop. We investigated whether strontium could regulate the imbalance of fast resorption of allograft and slower formation of new bone, because it is both an anabolic and an anticatabolic agent. Strontium was added to the implant interface environment by doping a hydroxyapatite bone graft extender. 10 dogs each received 2 experimental titanium implants. The implants were inserted within a 2.7-mm concentric gap in cancellous bone. The gap was filled with 50% (v/v) allograft mixed with 50% bone graft extender. The extender either had 5% strontium doping (SrHA) or was undoped (HA). After 4 weeks, osseointegration and mechanical fixation were evaluated by histomorphometry and by push-out test. SrHA bone graft extender induced a 1.2-fold increase in volume of new bone, a 1.2-fold increase in allograft remaining in the gap, and a 1.4-fold increase in surface area of the bone graft extender material in contact with new bone compared to HA bone graft extender. All these increases were statistically significant. SrHA bone graft extender did not significantly improve ongrowth of bone onto the implants or improve any of the mechanical push-out parameters compared to HA bone graft extender. Doping of the HA bone graft extender with 5% strontium increased gap healing, preserved more of the allograft in the gap, and increased the ongrowth of bone onto the bone graft extender material, but did not improve mechanical fixation.

Product Number
Product Description

Calcium chloride dihydrate, ACS reagent, ≥99%
Sodium phosphate, 96%
Calcium chloride dihydrate, for molecular biology, ≥99.0%
Calcium chloride dihydrate, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥99.0%
Calcium chloride dihydrate, ReagentPlus®, ≥99.0%
Strontium chloride hexahydrate, ACS reagent, 99%
Calcium chloride dihydrate, BioXtra, ≥99.0%
Calcium chloride dihydrate, BioUltra, for molecular biology, ≥99.5% (KT)
Calcium chloride dihydrate, puriss. p.a., ACS reagent, reag. Ph. Eur., ≥99%
Calcium chloride dihydrate, tested according to Ph. Eur.
Calcium chloride dihydrate, puriss., meets analytical specification of Ph. Eur., USP, FCC, E509, 99-103%, ≤0.0001% Al
Strontium chloride hexahydrate, 99.995% trace metals basis

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon


Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.